$0.990
+0.028 (+2.80%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
該買進 Scienture Holdings Inc 股票嗎？
TRxADE Health Inc is not a good buy right now due to its significant losses and declining performance. The current price is $0.96, which reflects a staggering year-to-date change of -72.71%. Additionally, the forward P/E ratio is 0, indicating no expected earnings growth, and the gross margin is a concerning -9.80% as of Q2 2026. The main risk is the company's negative net income, which reached -$18,363,225 in Q2 2026, highlighting ongoing financial instability.
MEDS 股價於 Tuesday 收在 $0.99，此前上漲 +2.80%
Scienture Holdings Inc (MEDS) last closed at $0.99, gaining +2.80%. These facts feed the 1-day and 1-week MEDS price prediction above.
預測驅動因素
Scienture Holdings Inc（MEDS）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Seasonality
Bearish
MEDS 季節性分析
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。